http://nova.newcastle.edu.au/vital/access/services/Feed ${session.getAttribute("locale")} 5 http://nova.newcastle.edu.au/vital/access/manager/Repository/uon:294 Abstract of WO2005021129 The present invention relates to methods for the separation of materials from heterogeneous fluids and provides a means of effecting stimulant-sensitive flocculation and consolidation of solid suspensions within a liquid medium. Specifically, the present invention provides a method of controlling the state of a suspension of solid particles in a liquid, including applying to the suspension a stimulus adapted to control inter-particle forces between the solid particles. The stimulus is reversibly operable to control attraction and/or repulsion. Means of consolidating a sediment bed and of separating the resultant liquids-rich and solids-rich phases are also within the ambit of the invention. 2010-04-27T06:02:27.859Z ]]> http://nova.newcastle.edu.au/vital/access/manager/Repository/uon:112 Abstract of WO2005077409 There is disclosed vaccines formulated for administration to the mucosa of the lungs of a mammal, and the use thereof in methods for prophylaxis or treatment of an infection by at least one pathogenic microorganism. The vaccines comprise a cellular fraction of the microorganism that is essentially free of particulate matter and includes polyvalent soluble antigen from the microorganism 2010-04-27T05:58:45.432Z ]]> http://nova.newcastle.edu.au/vital/access/manager/Repository/uon:124 2010-04-27T05:58:42.368Z ]]> http://nova.newcastle.edu.au/vital/access/manager/Repository/uon:102 2010-04-27T05:58:14.524Z ]]> http://nova.newcastle.edu.au/vital/access/manager/Repository/uon:481 Abstract of WO2005049009. There are disclosed methods for inhibiting dynamin-dependent endocytosis in cells comprising treating the cells with an effective amount of a compound of formula (I), or a dimeric tyrphostin, physiologically acceptable salt, or prodrug thereof. Compounds useful in the methods described are also provided. The inhibition of dynamin-dependent endocytosis of cells is applicable to the treatment of epilepsy and neurological disorders and conditions. 2010-04-27T05:48:10.238Z ]]> http://nova.newcastle.edu.au/vital/access/manager/Repository/uon:85 The present invention relates to probiotic Propionibacterium strains and their use in the preparation of probiotic supplements and foods. The invention relates to the provision of Vitamin B₁₂, propionic acid, folacin and bacteriocins by probiotic strains, stimulation of bifidobacteria growth, production of favourable effects on the lipid metabolism and on the immune system of hosts through immunostimulation, immunomodulation or use of a probiotic strain as an adjuvant, reduction of homocysteine and beta glucuronidase and the prevention, treatment or amelioration of conditions associated with a need for these activities. The probiotic bacteria of the invention can be used in humans or other animals. In at least some applications, the bacteria can be used dead and parts rather than whole cells may be used. The present invention also relates to the preparation of vaccines for use in protecting patients from infectious diseases, in particular tuberculosis. 2010-04-27T05:36:50.919Z ]]> http://nova.newcastle.edu.au/vital/access/manager/Repository/uon:19 2010-04-27T05:35:32.334Z ]]>